105 related articles for article (PubMed ID: 36267491)
1. Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study.
Shafiee G; Arastou T; Heshmat R; Jamshidi AR; Larijani B; Arzaghi SM
J Diabetes Metab Disord; 2022 Dec; 21(2):2013-2016. PubMed ID: 36267491
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. The Combined Use of Neuropsychiatric and Neuropsychological Assessment Tools to Make a Differential Dementia Diagnosis in the Presence of "Long-Haul" COVID-19.
Light SN
Case Rep Neurol; 2022; 14(1):130-148. PubMed ID: 35431881
[TBL] [Abstract][Full Text] [Related]
4. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
5. Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case report.
Jozuka R; Kimura H; Uematsu T; Fujigaki H; Yamamoto Y; Kobayashi M; Kawabata K; Koike H; Inada T; Saito K; Katsuno M; Ozaki N
Neuropsychopharmacol Rep; 2022 Mar; 42(1):114-119. PubMed ID: 34889531
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.
Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY
Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
[TBL] [Abstract][Full Text] [Related]
8. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions.
Han Y; Yuan K; Wang Z; Liu WJ; Lu ZA; Liu L; Shi L; Yan W; Yuan JL; Li JL; Shi J; Liu ZC; Wang GH; Kosten T; Bao YP; Lu L
Transl Psychiatry; 2021 Sep; 11(1):499. PubMed ID: 34593760
[TBL] [Abstract][Full Text] [Related]
10. Post COVID - 19 neurological disorders; a single center experience; a case series.
Ahmad SA; Mohammed SH; Abdulla BA; Salih BK; Hassan MN; Salih AM; Kakamad FH; Abdullah HO; Hassan HA; Othman S; Sidiq SH
Ann Med Surg (Lond); 2022 Apr; 76():103508. PubMed ID: 35371472
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2/COVID-19 associated pediatric acute-onset neuropsychiatric syndrome a case report of female twin adolescents.
Efe A
Psychiatry Res Case Rep; 2022 Dec; 1(2):100074. PubMed ID: 36267397
[TBL] [Abstract][Full Text] [Related]
12. Post-COVID syndrome. A case series and comprehensive review.
Anaya JM; Rojas M; Salinas ML; Rodríguez Y; Roa G; Lozano M; Rodríguez-Jiménez M; Montoya N; Zapata E; ; Monsalve DM; Acosta-Ampudia Y; Ramírez-Santana C
Autoimmun Rev; 2021 Nov; 20(11):102947. PubMed ID: 34509649
[TBL] [Abstract][Full Text] [Related]
13. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
15. Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.
Ishaq H; Durrani T; Umar Z; Khan N; McCombe P; Ul Haq MA
Front Neurol; 2021; 12():672524. PubMed ID: 34163427
[No Abstract] [Full Text] [Related]
16. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature.
Sriwastava S; Shrestha AK; Khalid SH; Colantonio MA; Nwafor D; Srivastava S
Neurol Int; 2021 Nov; 13(4):622-639. PubMed ID: 34842783
[No Abstract] [Full Text] [Related]
18. Long COVID and neuropsychiatric manifestations (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Smyrnis N; Rizos E
Exp Ther Med; 2022 May; 23(5):363. PubMed ID: 35493431
[TBL] [Abstract][Full Text] [Related]
19. TNF-α inhibitors in the treatment of hidradenitis suppurativa.
Savage KT; Flood KS; Porter ML; Kimball AB
Ther Adv Chronic Dis; 2019; 10():2040622319851640. PubMed ID: 31191873
[TBL] [Abstract][Full Text] [Related]
20. Post-acute COVID-19 functional movement disorder.
Garg A; Goyal S; Comellas AP
SAGE Open Med Case Rep; 2021; 9():2050313X211039377. PubMed ID: 34408879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
